股本结构
单位:万股
公告日期 | 2024-04-11 | 2024-02-27 | 2024-01-22 | 2024-02-27 | 2023-11-07 | 2023-11-07 |
---|---|---|---|---|---|---|
证券总股本 | 18940.06 | 18505.27 | 17041.78 | 11821.03 | 11371.78 | 11213.64 |
普通股本 | 18940.06 | 18505.27 | 17041.78 | 11821.03 | 11371.78 | 11213.64 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-03-26 | 2024-02-15 | 2024-01-23 | 2023-12-31 | 2023-11-01 | 2023-09-30 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-04-11 | 18940.06 | 未披露 | 定期报告 | 2024-03-26 |
2024-02-27 | 18505.27 | 未披露 | 定期报告 | 2024-02-15 |
2024-01-22 | 17041.78 | 未披露 |
更多>>
Common stock offered 56,700,000 shares by the company
|
2024-01-23 |
2024-02-27 | 11821.03 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock from ATM Program, net of issuance costs
Vesting of restricted stock units and performance-based restricted stock units
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs
Vesting of ESPP Shares
Exercise of pre-funded warrants
Exercise of warrants
|
2023-12-31 |
2023-11-07 | 11371.78 | 未披露 | 定期报告 | 2023-11-01 |
2023-11-07 | 11213.64 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Vesting of restricted stock units
Vesting of ESPP Shares
Exercise of pre-funded warrants
|
2023-09-30 |
2023-08-01 | 10699.43 | 未披露 | 定期报告 | 2023-07-28 |
2023-08-01 | 10087.05 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock from ATM program, net of issuance costs
Exercise of pre-funded warrants
Vesting of restricted stock units
|
2023-06-30 |
2023-05-09 | 9471.27 | 未披露 | 定期报告 | 2023-05-01 |
2023-05-09 | 8724.30 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Vesting of restricted stock units and performance-based restricted stock units
Vesting of ESPP Shares
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs
|
2023-03-31 |
2023-04-13 | 8907.14 | 未披露 | 定期报告 | 2023-03-28 |
2023-03-22 | 10974.36 | 未披露 |
更多>>
Common Stock offered 12,205,000 shares by the company.
The Company agreed to issue and sell, in a registered direct offering (the “Offering”), 12,205,000 shares of its common stock, par value $0.001 per share (the “Common Stock”), pre-funded warrants to purchase up to an aggregate of 20,965,747 shares of Common Stock (the “Pre-Funded Warrants”) in lieu of shares of Common Stock.
|
2023-03-22 |
2023-02-21 | 7657.28 | 未披露 | 定期报告 | 2023-02-01 |
2023-02-21 | 7457.02 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock from ATM Program, net of issuance costs
Vesting of restricted stock units
Vesting of ESPP Shares
|
2022-12-31 |
2022-11-01 | 7368.36 | 未披露 | 定期报告 | 2022-10-31 |
2022-11-01 | 7174.51 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units
Vesting of ESPP Shares
Issuance of common stock from ATM program, net of issuance costs
|
2022-09-30 |
2022-08-18 | 6655.16 | 未披露 | 定期报告 | 2022-08-02 |
2022-08-02 | 6655.15 | 未披露 | 定期报告 | 2022-08-01 |
2022-08-02 | 6459.60 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock from ATM program, net of issuance costs
Vesting of restricted stock units
|
2022-06-30 |
2022-05-03 | 6300.66 | 未披露 | 定期报告 | 2022-05-01 |
2022-05-03 | 6105.86 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Vesting of restricted stock units
Vesting of ESPP Shares
|
2022-03-31 |
2022-04-14 | 6298.13 | 未披露 | 定期报告 | 2022-03-29 |
2022-02-22 | 6282.16 | 未披露 | 定期报告 | 2022-02-01 |
2022-02-22 | 6087.95 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock and warrants from offering, net of issuance costs
Issuance of common stock from ATM Program, net of issuance costs
Exchange of convertible notes to equity, net of issuance costs
Exercise of stock options
Vesting of restricted stock units
Vesting of ESPP Shares
|
2021-12-31 |
2021-12-07 | 6203.23 | 未披露 |
更多>>
1.Common stock offered by company 32,142,858 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 29,889,415 shares of common stock outstanding as of September 30, 2021.
|
2021-12-07 |
2021-11-02 | 2907.74 | 未披露 | 定期报告 | 2021-11-01 |
2021-11-02 | 2680.04 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock, net of issuance costs
Exercise of stock options
Vesting of restricted stock units
Vesting of ESPP Shares
|
2021-09-30 |
2021-08-03 | 2827.75 | 未披露 | 定期报告 | 2021-08-01 |
2021-08-03 | 2627.43 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options
Vesting of restricted stock units
|
2021-06-30 |
2021-05-04 | 2819.21 | 未披露 | 定期报告 | 2021-05-01 |
2021-05-04 | 2618.27 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Exercise of stock options
Vesting of restricted stock units
Vesting of ESPP Shares
|
2021-03-31 |
2021-04-15 | 2815.60 | 未披露 | 定期报告 | 2021-03-29 |
2021-02-23 | 2794.26 | 未披露 | 定期报告 | 2021-02-01 |
2021-02-23 | 2791.04 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Exercise of stock options
Vesting of restricted stock units
Repurchase of common stock under prepaid forward contract
|
2020-12-31 |
2020-11-02 | 2787.66 | 未披露 | 定期报告 | 2020-11-01 |
2020-11-02 | 2785.63 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of stock options
Vesting of restricted stock units
|
2020-09-30 |
2020-08-10 | 2782.54 | 未披露 | 定期报告 | 2020-08-01 |
2020-08-10 | 2775.17 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of stock options
Vesting of restricted stock units
|
2020-06-30 |
2020-05-06 | 2761.74 | 未披露 | 定期报告 | 2020-05-01 |
2020-05-06 | 2754.81 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Exercise of stock options
Vesting of restricted stock units
|
2020-03-31 |
2020-04-16 | 2754.58 | 未披露 | 定期报告 | 2020-03-20 |
2020-02-27 | 2751.24 | 未披露 | 定期报告 | 2020-02-01 |
2020-02-27 | 2749.79 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Exercise of stock options
Vesting of restricted stock units
Exercise of warrants
|
2019-12-31 |
2019-11-06 | 2732.74 | 未披露 | 定期报告 | 2019-11-01 |
2019-11-06 | 2717.82 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Exercise of stock options
Vesting of restricted stock units
|
2019-09-30 |
2019-08-08 | 2717.07 | 未披露 | 定期报告 | 2019-08-01 |
2019-08-08 | 2703.67 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Exercise of stock options
Exercise of warrants
Vesting of restricted stock units
|
2019-06-30 |
2019-05-08 | 2691.75 | 未披露 | 定期报告 | 2019-05-01 |
2019-05-08 | 2690.82 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Exercise of stock options
Vesting of restricted stock units
|
2019-03-31 |
2019-04-18 | 2687.96 | 未披露 | 定期报告 | 2019-03-20 |
2019-02-28 | 2682.49 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Exercise of stock options
Exercise of warrants
Vesting of restricted stock units
|
2018-12-31 |
2018-11-01 | 2681.10 | 未披露 | 定期报告 | 2018-10-31 |
2018-11-01 | 2680.43 | 未披露 | 定期报告 | 2018-09-30 |
2018-08-02 | 2680.37 | 未披露 | 定期报告 | 2018-08-01 |
2018-08-02 | 2680.17 | 未披露 | 定期报告 | 2018-06-30 |
2018-05-02 | 2678.56 | 未披露 | 定期报告 | 2018-05-01 |
2018-05-02 | 2675.16 | 未披露 | 定期报告 | 2018-03-31 |
2018-04-13 | 2675.16 | 未披露 | 定期报告 | 2018-03-26 |
2018-04-13 | 2672.82 | 未披露 | 定期报告 | 2018-03-01 |
2018-02-20 | 2649.93 | 未披露 | 定期报告 | 2018-02-01 |
2018-02-20 | 2630.47 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common stock from public offering, net of issuance costs ($226)
Exercise of stock options
Exercise of warrants
Vesting of restricted stock units
|
2017-12-31 |
2017-11-07 | 2619.77 | 未披露 | 定期报告 | 2017-11-01 |
2017-11-07 | 2618.75 | 未披露 | 定期报告 | 2017-09-30 |
2017-08-08 | 2259.32 | 未披露 | 定期报告 | 2017-06-30 |
2017-05-04 | 2259.00 | 未披露 | 定期报告 | 2017-05-01 |
2017-05-04 | 2258.85 | 未披露 | 定期报告 | 2017-03-31 |
2017-03-06 | 2255.60 | 未披露 | 定期报告 | 2017-02-17 |
2017-02-22 | 2255.54 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Exercise of stock options
Vesting of restricted stock units
|
2016-12-31 |
2016-11-03 | 2255.39 | 未披露 | 定期报告 | 2016-09-30 |
2016-08-04 | 2255.04 | 未披露 | 定期报告 | 2016-08-01 |
2016-08-04 | 2254.48 | 未披露 | 定期报告 | 2016-06-30 |
2016-05-04 | 2254.10 | 未披露 | 定期报告 | 2016-05-01 |
2016-04-28 | 2254.05 | 未披露 | 定期报告 | 2016-04-11 |
2016-05-04 | 2253.99 | 未披露 | 定期报告 | 2016-03-31 |
2016-02-25 | 2254.05 | 未披露 | 定期报告 | 2016-02-01 |
2016-02-25 | 2251.65 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Issuance of common stock from public offering, net of issuance costs ($199)
Exercise of stock options
Exercise of warrants
|
2015-12-31 |
2015-12-22 | 2251.89 | 未披露 | 定期报告 | 2015-12-15 |
2015-11-05 | 2251.89 | 未披露 | 定期报告 | 2015-11-01 |
2015-11-05 | 2251.47 | 未披露 | 定期报告 | 2015-09-30 |
2015-08-06 | 2248.87 | 未披露 | 定期报告 | 2015-08-01 |
2015-08-06 | 2248.28 | 未披露 | 定期报告 | 2015-06-30 |
2015-05-07 | 2245.96 | 未披露 | 定期报告 | 2015-05-01 |
2015-05-07 | 2244.76 | 未披露 | 定期报告 | 2015-03-31 |
2015-04-01 | 2043.73 | 未披露 | 定期报告 | 2015-03-16 |
2015-03-10 | 2042.59 | 未披露 | 定期报告 | 2015-03-01 |
2015-03-10 | 2034.33 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Issuance of common stock from public offering, net of issuance costs ($260)
Exercise of stock options
|
2014-12-31 |
2014-12-22 | 2034.98 | 未披露 | 定期报告 | 2014-12-15 |
2014-11-10 | 2034.98 | 未披露 |
更多>>
In October 2014, the Company completed an underwritten public offering of 4,887,500 shares of common stock, including 637,500 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters.
|
2014-11-01 |
2014-11-10 | 1544.36 | 未披露 | 定期报告 | 2014-09-30 |
2014-08-12 | 1544.50 | 未披露 | 定期报告 | 2014-08-01 |
2014-08-12 | 1543.19 | 未披露 | 定期报告 | 2014-06-30 |
2014-06-30 | 1543.80 | 未披露 | 定期报告 | 2014-06-02 |
2014-05-12 | 1539.42 | 未披露 | 定期报告 | 2014-05-01 |
2014-05-12 | 1537.93 | 未披露 | 定期报告 | 2014-03-31 |
2014-03-13 | 1539.42 | 未披露 | 定期报告 | 2014-03-01 |
2014-03-13 | 1534.07 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Issuance of Series A preferred stock in exchange for convertible promissory notes
Issuance of Series A preferred stock, net of issuance costs ($119,537)
Preferred shares converted into common stock
Early exercise of stock options and vesting of restricted stock
Issuance of common stock from initial public offering, net of issuance costs ($2,671,169)
Exercise of stock options
|
2013-12-31 |
2013-11-06 | 1535.74 | 未披露 | 定期报告 | 2013-11-01 |
2013-11-06 | 1533.52 | 未披露 |
更多>>
from June 30, 2013 to September 30, 2013
Conversion of Series A preferred stock into common stock upon closing of IPO
Conversion of Series A-1 preferred stock into common stock upon closing of IPO
Issuance of common stock to underwriters due to exercise of over-allotment
|
2013-09-30 |
2013-08-12 | 1535.74 | 未披露 |
更多>>
As of June 30, 2013, the Company had outstanding warrants to purchase a total of 1,940,000 shares of its Series A preferred stock at an exercise price of $1.00 per share. On July 1, 2013, upon the closing of the IPO, the warrants became exercisable for a total of 277,690 shares of common stock at an exercise price of $6.99 per share. The Company is evaluating the impact of the IPO on the balance sheet classification of the outstanding warrants.
|
2013-08-01 |
2013-08-12 | 37.21 | 6434.81 | 定期报告 | 2013-06-30 |
2013-06-26 | 1457.93 | 未披露 |
更多>>
the conversion of all of our outstanding shares of preferred stock, including (i) the 17,000,000 shares of Series A preferred stock issued on April 19, 2013 and (ii) the 6,750,000 shares of Series A-1 preferred stock issued on May 29, 2013, into an aggregate of 9,210,999 shares of common stock upon the closing of this offering
a 1-for-6.986 reverse split of our common stock effected on June 11, 2013
|
2013-06-26 |
2013-06-12 | 34.65 | 4059.81 |
更多>>
On June 11, 2013, the Company effectuated a 1-for-6.986 reverse stock split of its outstanding common stock, which was approved by the Company's board of directors on June 5, 2013.
|
2013-06-11 |
2013-06-07 | 6692.11 | 未披露 | 定期报告 | 2013-05-31 |
2013-05-14 | 6002.11 | 未披露 | 定期报告 | 2013-04-30 |
2013-05-14 | 242.05 | 4059.81 |
更多>>
From December 31,2012 to March 31,2013
Issuance of Series A preferred stock on February 12, 2013 in exchange for convertible promissory notes
|
2013-03-31 |
Common stock offered 56,700,000 shares by the company
From December 31, 2022 to December 31, 2023
Issuance of common stock from ATM Program, net of issuance costs
Vesting of restricted stock units and performance-based restricted stock units
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs
Vesting of ESPP Shares
Exercise of pre-funded warrants
Exercise of warrants
From June 30, 2023 to September 30, 2023
Vesting of restricted stock units
Vesting of ESPP Shares
Exercise of pre-funded warrants
From March 31, 2023 to June 30, 2023
Issuance of common stock from ATM program, net of issuance costs
Exercise of pre-funded warrants
Vesting of restricted stock units
From December 31, 2022 to March 31, 2023
Vesting of restricted stock units and performance-based restricted stock units
Vesting of ESPP Shares
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs
Common Stock offered 12,205,000 shares by the company.
The Company agreed to issue and sell, in a registered direct offering (the “Offering”), 12,205,000 shares of its common stock, par value $0.001 per share (the “Common Stock”), pre-funded warrants to purchase up to an aggregate of 20,965,747 shares of Common Stock (the “Pre-Funded Warrants”) in lieu of shares of Common Stock.
From December 31, 2021 to December 31, 2022
Issuance of common stock from ATM Program, net of issuance costs
Vesting of restricted stock units
Vesting of ESPP Shares
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units
Vesting of ESPP Shares
Issuance of common stock from ATM program, net of issuance costs
From March 31, 2022 to June 30, 2022
Issuance of common stock from ATM program, net of issuance costs
Vesting of restricted stock units
From December 31, 2021 to March 31, 2022
Vesting of restricted stock units
Vesting of ESPP Shares
From December 31, 2020 to December 31, 2021
Issuance of common stock and warrants from offering, net of issuance costs
Issuance of common stock from ATM Program, net of issuance costs
Exchange of convertible notes to equity, net of issuance costs
Exercise of stock options
Vesting of restricted stock units
Vesting of ESPP Shares
1.Common stock offered by company 32,142,858 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 29,889,415 shares of common stock outstanding as of September 30, 2021.
From June 30, 2021 to September 30, 2021
Issuance of common stock, net of issuance costs
Exercise of stock options
Vesting of restricted stock units
Vesting of ESPP Shares
From March 31, 2021 to June 30, 2021
Exercise of stock options
Vesting of restricted stock units
From January 1, 2021 to March 31, 2021
Exercise of stock options
Vesting of restricted stock units
Vesting of ESPP Shares
From December 31, 2019 to December 31, 2020
Exercise of stock options
Vesting of restricted stock units
Repurchase of common stock under prepaid forward contract
From June 30, 2020 to September 30, 2020
Exercise of stock options
Vesting of restricted stock units
From March 31, 2020 to June 30, 2020
Exercise of stock options
Vesting of restricted stock units
from December 31, 2019 to March 31, 2020
Exercise of stock options
Vesting of restricted stock units
from December 31, 2018 to December 31, 2019
Exercise of stock options
Vesting of restricted stock units
Exercise of warrants
From June 30, 2019 to September 30, 2019
Exercise of stock options
Vesting of restricted stock units
From March 31, 2019 to June 30, 2019
Exercise of stock options
Exercise of warrants
Vesting of restricted stock units
from December 31, 2018 to March 31, 2019
Exercise of stock options
Vesting of restricted stock units
from December 31, 2017 to December 31, 2018
Exercise of stock options
Exercise of warrants
Vesting of restricted stock units
from December 31, 2016 to December 31, 2017
Issuance of common stock from public offering, net of issuance costs ($226)
Exercise of stock options
Exercise of warrants
Vesting of restricted stock units
from December 31, 2015 to December 31, 2016
Exercise of stock options
Vesting of restricted stock units
from December 31, 2014 to December 31, 2015
Issuance of common stock from public offering, net of issuance costs ($199)
Exercise of stock options
Exercise of warrants
from December 31, 2013 to December 31, 2014
Issuance of common stock from public offering, net of issuance costs ($260)
Exercise of stock options
In October 2014, the Company completed an underwritten public offering of 4,887,500 shares of common stock, including 637,500 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters.
from December 31, 2012 to December 31, 2013
Issuance of Series A preferred stock in exchange for convertible promissory notes
Issuance of Series A preferred stock, net of issuance costs ($119,537)
Preferred shares converted into common stock
Early exercise of stock options and vesting of restricted stock
Issuance of common stock from initial public offering, net of issuance costs ($2,671,169)
Exercise of stock options
from June 30, 2013 to September 30, 2013
Conversion of Series A preferred stock into common stock upon closing of IPO
Conversion of Series A-1 preferred stock into common stock upon closing of IPO
Issuance of common stock to underwriters due to exercise of over-allotment
As of June 30, 2013, the Company had outstanding warrants to purchase a total of 1,940,000 shares of its Series A preferred stock at an exercise price of $1.00 per share. On July 1, 2013, upon the closing of the IPO, the warrants became exercisable for a total of 277,690 shares of common stock at an exercise price of $6.99 per share. The Company is evaluating the impact of the IPO on the balance sheet classification of the outstanding warrants.
the conversion of all of our outstanding shares of preferred stock, including (i) the 17,000,000 shares of Series A preferred stock issued on April 19, 2013 and (ii) the 6,750,000 shares of Series A-1 preferred stock issued on May 29, 2013, into an aggregate of 9,210,999 shares of common stock upon the closing of this offering
a 1-for-6.986 reverse split of our common stock effected on June 11, 2013
On June 11, 2013, the Company effectuated a 1-for-6.986 reverse stock split of its outstanding common stock, which was approved by the Company's board of directors on June 5, 2013.
From December 31,2012 to March 31,2013
Issuance of Series A preferred stock on February 12, 2013 in exchange for convertible promissory notes